Westlake BioPartners Opportunity Fund I, L.P. is 10% Owner at Kyverna Therapeutics, Inc. (KYTX). They have made 1 open-market trade across 1 company since 2025, most recently 2025-12-18.
CIK 0001811946
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $1000K since 2025, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| KYTX | 869,317 | $4.9M |
Shares reported on the most recent Form 4, priced at the 2025-12-22 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KYTX | BUY | 2025-12-18 | 2025-12-22 | $7.50 | $1000K | +0.2% | +16.9% | -3.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.